sur Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Protagonist Therapeutics to Engage at Evercore ISI HealthCONx Conference
Protagonist Therapeutics, Inc. announced that its President and CEO, Dr. Dinesh V. Patel, will engage in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. The event is scheduled from December 3-5, 2024, in Coral Gables, Florida. The company also plans to conduct one-on-one meetings during the conference.
The fireside chat is set for December 3 at 8:45 A.M. ET. A webcast of the chat will be accessible, with a replay available on Protagonist's Investor Relations webpage for one year.
Protagonist is a late-stage biopharmaceutical company with two peptides in advanced Phase 3 development. Icotrokinra targets IL-23 receptor-related diseases and is in Phase 3 for psoriasis. Rusfertide addresses polycythemia vera and is in Phase 3 development.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Protagonist Therapeutics, Inc.